Entering text into the input field will update the search result below

Digital Diabetes Management Market: Insulet Corporation Collaborated With SAMSUNG To Enhance Consumer-Based Digital Health Technologies.

Mar. 31, 2021 3:33 AM ETMedtronic plc (MDT), DXCM, ABT, RHHBY, PODD, TNDM, SSNLF
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Digital Diabetes Management Market Overview.

This report aims to provide detailed insights into the global digital diabetes management market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Key Factors Driving Market Growth:

The major factors driving the growth of this market include the rising prevalence of diabetes, technological advancements, increasing adoption of cloud-based enterprise solutions, and the growing use of connected devices and apps.

Revenue Growth Analysis:

The Digital Diabetes Management Industry is projected to reach USD 19.9 billion by 2024 from an estimated USD 6.8 billion in 2019, at a CAGR of 23.8%.

Don't miss out on business opportunities in Digital Diabetes Management Market

By product & service, the devices segment accounted for the largest share of the Digital Diabetes Management Market

Based on product & service, the market is divided into devices, apps, data management software & platforms, and services. The devices segment accounted for the largest market share in 2018. The growing demand for wireless and wearable devices for diabetes management, growing acceptance of smart insulin pumps & pens for insulin delivery, technological innovations & digital advancements in devices, and increasing awareness about continuous glucose monitoring in patients are the key factors driving the growth of the devices segment.

Browse in-depth TOC on "Digital Diabetes Management Market"

144 - Tables

42 - Figures

219 - Pages

Download PDF Brochure:

Digital Diabetes Management Market

Wearable devices segment to witness the highest growth in the digital diabetes management devices market, by type

Based on type, the digital diabetes management devices industry is segmented into wearable devices and handheld devices. The wearable devices segment accounted for the largest share of the digital diabetes management devices market in 2018. The large share of this segment can be attributed to the increasing number of regulatory approvals for CGM systems; technological advancements such as closed-loop pump systems, smart insulin patches, and other pipeline devices; and the growing adoption of smart insulin pumps and insulin patches for self-insulin delivery in diabetes management.

Digital Diabetes Management Market

North America, the largest regional market for digital diabetes management

North America accounted for the largest share of the Digital Diabetes Management Market in 2018, followed by Europe and the Asia Pacific. Factors such as growing adoption of connected diabetes management devices, high adoption of diabetes management apps, growing demand for integrated hybrid closed-loop systems, favorable reimbursement policies, and government initiatives to promote digital health in the region are driving the growth of the Digital Diabetes Management Industry in North America.

Request Sample Report@

Digital Diabetes Management Market

Prominent players in the Digital Diabetes Management Market are Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel).

Medtronic is the leading player in the digital diabetes management industry. The company’s leading position in this market is attributed to its strong geographical presence and wide product portfolio, which includes insulin pumps, smart glucose meters, CGM systems, mobile applications, data management software, and services.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Related Stocks

SymbolLast Price% Chg
Medtronic plc
DexCom, Inc.
Abbott Laboratories
Roche Holding AG
Insulet Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.